| Product Code: ETC9972852 | Publication Date: Sep 2024 | Updated Date: Apr 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In 2024, the United States continued to rely on key suppliers such as India, Italy, Slovenia, Belgium, and Denmark for its paracetamol IV import shipments. The market exhibited low concentration levels with a Herfindahl-Hirschman Index (HHI) remaining stable. Despite a strong compound annual growth rate (CAGR) of 11.26% from 2020 to 2024, there was a notable decline in growth rate from 2023 to 2024 by -32.38%. This indicates a potential shift in market dynamics or temporary challenges impacting the import of paracetamol IV into the US.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) Paracetamol IV Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) Paracetamol IV Market Revenues & Volume, 2022 & 2032F |
3.3 United States (US) Paracetamol IV Market - Industry Life Cycle |
3.4 United States (US) Paracetamol IV Market - Porter's Five Forces |
3.5 United States (US) Paracetamol IV Market Revenues & Volume Share, By Indication, 2022 & 2032F |
3.6 United States (US) Paracetamol IV Market Revenues & Volume Share, By Application, 2022 & 2032F |
3.7 United States (US) Paracetamol IV Market Revenues & Volume Share, By End-use, 2022 & 2032F |
4 United States (US) Paracetamol IV Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of fever, pain, and other conditions requiring intravenous administration of paracetamol |
4.2.2 Growing awareness about the benefits and efficacy of paracetamol IV in healthcare settings |
4.2.3 Rising demand for quick and effective pain relief options in hospitals and clinics |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements and approval processes for IV medications |
4.3.2 Competition from alternative pain management drugs and treatments |
4.3.3 Concerns regarding potential side effects and safety of paracetamol IV usage |
5 United States (US) Paracetamol IV Market Trends |
6 United States (US) Paracetamol IV Market, By Types |
6.1 United States (US) Paracetamol IV Market, By Indication |
6.1.1 Overview and Analysis |
6.1.2 United States (US) Paracetamol IV Market Revenues & Volume, By Indication, 2022 - 2032F |
6.1.3 United States (US) Paracetamol IV Market Revenues & Volume, By Pain, 2022 - 2032F |
6.1.4 United States (US) Paracetamol IV Market Revenues & Volume, By Pyrexia (Fever), 2022 - 2032F |
6.2 United States (US) Paracetamol IV Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 United States (US) Paracetamol IV Market Revenues & Volume, By Surgical, 2022 - 2032F |
6.2.3 United States (US) Paracetamol IV Market Revenues & Volume, By Non-surgical, 2022 - 2032F |
6.3 United States (US) Paracetamol IV Market, By End-use |
6.3.1 Overview and Analysis |
6.3.2 United States (US) Paracetamol IV Market Revenues & Volume, By Hospitals, 2022 - 2032F |
6.3.3 United States (US) Paracetamol IV Market Revenues & Volume, By Clinics, 2022 - 2032F |
6.3.4 United States (US) Paracetamol IV Market Revenues & Volume, By Others, 2022 - 2032F |
7 United States (US) Paracetamol IV Market Import-Export Trade Statistics |
7.1 United States (US) Paracetamol IV Market Export to Major Countries |
7.2 United States (US) Paracetamol IV Market Imports from Major Countries |
8 United States (US) Paracetamol IV Market Key Performance Indicators |
8.1 Average length of hospital stay for patients receiving paracetamol IV |
8.2 Number of hospitals or healthcare facilities adopting paracetamol IV in their treatment protocols |
8.3 Patient satisfaction scores related to pain management and overall experience with paracetamol IV administration. |
9 United States (US) Paracetamol IV Market - Opportunity Assessment |
9.1 United States (US) Paracetamol IV Market Opportunity Assessment, By Indication, 2022 & 2032F |
9.2 United States (US) Paracetamol IV Market Opportunity Assessment, By Application, 2022 & 2032F |
9.3 United States (US) Paracetamol IV Market Opportunity Assessment, By End-use, 2022 & 2032F |
10 United States (US) Paracetamol IV Market - Competitive Landscape |
10.1 United States (US) Paracetamol IV Market Revenue Share, By Companies, 2025 |
10.2 United States (US) Paracetamol IV Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here